Shifting Tides: US Department of Health and Human Services Recommends Cannabis Rescheduling from Schedule I to Schedule III
By Madeline Colli, Erin McEvoy for Cannabis Science and Technology
On Wednesday, August 30th, the Department of Health and Human Services made its recommendation to the Drug Enforcement Agency to classify cannabis as a Schedule III drug, paving the way for reform, industry expansion, and research opportunities.
Causing ripples and waves in the cannabis industry, the US Department of Health and Human Services (HHS), one of the top government agencies, has taken the leap on recommending cannabis be rescheduled from a Schedule I drug to a Schedule III drug. The easing of cannabis restrictions is being celebrated from bipartisan lawmakers, such as Senator John Fetterman (D-PA) and Representative Dave Joyce (R-OH), who are also claiming partial credit for HHS’s recent action (1,2), which follows a review request from the Biden Administration last year (3).
Share this page
